$10.96
-0.51-4.45%
$11.00
-0.47-4.1%
Akari Therapeutics PLC
AKTXNASDAQ
Akari Therapeutics Earnings & Forecasts
Akari Therapeutics (AKTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Akari Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '23 | FY '22 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||||
| Estimate | $-1.04 | $-2.80 | $-2.80 | $-4.40 | — | — |
| Actual | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Surprise | +100.0% | +100.0% | +100.0% | +100.0% | — | — |
| Revenue | ||||||
| Estimate | — | — | — | — | — | — |
| Actual | — | $0 | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.04 | $-0.46 |
| Revenue | ||
| Consensus | — | — |
